Sara Elgaard Jager

Sara Elgaard Jager is a Researcher at the Department of Neuroscience within the Faculty of Health and Medical Sciences at the University of Copenhagen, specializing in the Neuropharm and Genetics research group. Her work bridges molecular neuroscience and pharmacology with clinical applications in pain and metabolic disorders.

Her primary research areas include glial cell mechanisms in chronic pain, development of targeted inhibitors for neurological conditions, and obesity therapeutics through glutamate receptor modulation. She employs advanced techniques like in vivo calcium imaging and murine disease models to investigate cellular pathways involved in pain sensitization and metabolic dysregulation, with particular focus on proteins such as PICK1 and PSD-95.

Analysis of her 2024 publications reveals a cohesive research trajectory targeting protein scaffolding complexes for therapeutic intervention. Her work demonstrates translational potential across pain management and obesity treatment, integrating molecular pharmacology, neuroimaging, and behavioral studies to develop peripherally restricted compounds that minimize central side effects.

Dr. Jager actively collaborates through the Neuropharm and Genetics group at the University of Copenhagen, maintaining international research networks evidenced by multi-institutional publications and social media engagement with her Science Advances paper reaching 25 Mendeley readers and 16 X users.